As organizations in every sector struggled to capture accurate and insightful information into the COVID-19 pandemic, ThinkData Works, a leading data aggregation and distribution company, worked with their clients to provide access to decision-grade data used by researchers and analysts to understand the crisis better.
One of ThinkData’s clients, a major pharmaceutical organization, was looking to identify and geo-locate specific countries and regions where people reported a greater incidence of COVID-19 and its symptoms. The data gathered would be used to support the company in the roll-out of clinical trials to populations that exhibit a greater incidence of the virus. Thinkdata’s client was interested in collecting data in Brazil, China, Russia, the US, Australia, Canada, Germany, France, Italy, Poland, Spain, the UK, Ukraine, Japan, South Korea, and Taiwan.
Using this data, the pharmaceutical client gained access to a rich source of sentiment data that helped provide immediate insight into ground-level perceptions of the disease, leading to increased awareness of how the pandemic was impacting local communities and where support was needed.
Forward-looking data is the only way to accurately see how the pandemic is spreading. Working with RIWI to design a custom survey instrument that pulled in individual sentiment data gave us granular, up-to-date information that could immediately be applied to better understand and mitigate the impact of COVID-19. Bryan Smith CEO, THINKDATA